Antiva Biosciences' Series C - II Round

Antiva Biosciences raised a round of funding on July 11, 2018.

Antiva Biosciences, formerly Hera Therapeutics, is a biopharmaceutical company developing topical therapeutics for the treatment of diseases caused by HPV infection.…

Articles about Antiva Biosciences' Series C - II Round: